What Has Been The Evolution of the Sanger Sequencing Market in Recent Years?
The sanger sequencing market has seen considerable growth due to a variety of factors.
• The market size of Sanger Sequencing has seen a significant expansion in the past few years. It is projected to rise from $2.75 billion in 2024 to $3.3 billion in 2025, witnessing a Compound Annual Growth Rate (CAGR) of 19.8%.
The heightened growth during the previous period is associated with a surge in research needs, enhancement in medical diagnostics, escalation in pharmaceutical development, rise in agricultural usage, amplification in forensic analysis, and an increase in biomarker discovery and genetic evolution studies.
What Are the Future Growth Projections for the Sanger Sequencing Market?
The sanger sequencing market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for Sanger sequencing is predicted to experience a swift expansion in the coming years, escalating to $6.17 billion by 2029, with a compound annual growth rate (CAGR) of 16.9%.
This surge for the forecasted period is associated with factors like escalating application of clinical genomics, broadened genomics in agriculture, enhanced drug safety and pharmacogenomics, increased prenatal and infant screening, and a rise in environmental DNA analysis. Significant trends during this phase will feature technological developments, an escalated need for next-generation sequencing, expanded use in clinical diagnostics, increased funding in genomic research, and widespread use in personalized medicine.
What Are The Core Factors Supporting Growth In The Sanger Sequencing Market?
The growth of the sanger sequencing market is anticipated to surge due to the increasing prevalence of genetic disorders. Genetic diseases, also known as genetic disorders, are health conditions resulting from anomalies or mutations in an individual's DNA, which is the genetic material carrying the blueprint of life. Sanger sequencing is utilized to identify genetic disorders by accurately establishing the sequence of nucleotides, or DNA building blocks, in a specific gene or DNA region. For example, the National Health Service, a publicly funded healthcare system based in the UK, reported in August 2024, that around 2,300 individuals in the UK live with thalassaemia as of 2024. Among these individuals, about 800 suffer from the severe form of thalassaemia and require regular blood transfusions. Accordingly, the escalation in genetic disorders is encouraging the growth of the sanger sequencing market.
What Are The Major Segments Within The Global Sanger Sequencing Market?
The sanger sequencing market covered in this report is segmented –
1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing
2) By Laboratory: Wet Labs, Dry Labs
3) By Research: In-House, Outsourced
4) By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications
5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics
Subsegments:
1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing, Metagenomic Shotgun Sequencing
2) By Targeted Gene Sequencing: Amplicon Sequencing, Exome Sequencing
3) By Other Sequencing: Nested PCR Sequencing, Sequencing By Synthesis (SBS)
Pre-Book The Sanger Sequencing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Sanger Sequencing Market?
Leading firms in the Sanger sequencing market are channeling their efforts into extending their genomic lab facilities, aiming to provide speedy Sanger sequencing services across the North of the UK. These genomic laboratories engage in carrying out genetic tests and scrutinizing to learn about the organization, functioning, and transmission of genes and genomes, and are typically used for diagnostic purposes, research and individualized medicine. To illustrate, Source Genomics, a UK-based company that provides genomic services, revealed in June 2023, their plans to broaden their genomic laboratory to the North of the UK. This expansion will enhance the efficiency of their Sanger sequencing services, making data delivery faster, and implying a significant step toward ensuring fair access to genomic services for research institutions nationwide. This expansion will enable patrons from across the country to avail of superior Sanger sequencing services with more efficient delivery times.
Who Are the Key Players In The Sanger Sequencing Market?
Major companies operating in the sanger sequencing market report are:
• Hoffmann-La Roche
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Eurofins Scientific
• Illumina Inc.
• Beckman Coulter
• PerkinElmer Inc.
• BGI Group
• LGC Limited
• GenScript
• Oxford Nanopore Technologies
• Pacific Biosciences of California Inc.
• Macrogen Inc.
• GENEWIZ Inc.
• Quintara Biosciences
• CeMIA SA
• Source BioScience
• Microsynth AG
• Fasteris SA
• GenHunter Corporation
• Nucleics Pty. Ltd.
• SciGenom Labs Pvt. Ltd.
• StarSEQ GmbH
• GATC Biotech AG
• Agilent Technologies
What Is The Most Dominant Region In The Sanger Sequencing Market?
North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
